Clinical Trial

A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System

Study acronym: CATALYSTEM
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-08-19; most recent amendment 2026-03-10.
Status change: Enrolling by Invitation → Active, Not Recruiting 2026-03-10
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-10-01
Trial Details
NCT Number NCT06564636
Lead Sponsor Smith & Nephew, Inc.
Conditions Total Hip Arthroplasty (THA), Osteoarthritis, Degenerative Joint Disease, Inflammatory Arthritis, Avascular Necrosis, Post-traumatic Arthritis, Congenital Hip Dysplasia
Enrollment 119 participants
Start Date 2024-09-26
Primary Completion 2027-12 (estimated)
Study Completion 2036-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-12